Aurora Cannabis (ACB) Treasury Shares (2018 - 2019)

Aurora Cannabis (ACB) posted quarterly Treasury Shares of $2.4 billion for Q1 2019, up 4.45% quarter-over-quarter from $2.3 billion in Q4 2018.

Aurora Cannabis (ACB) Treasury Shares (2018 - 2019) Analysis & Trends

Aurora Cannabis (ACB) has reported Treasury Shares for 2 consecutive years, with $2.4 billion the latest figure, recorded in Q1 2019.

In Q1 2019, Treasury Shares changed N/A year-over-year to $2.4 billion; the TTM figure through Mar 2019 stood at $2.4 billion (changed N/A YoY), while the FY2018 annual figure was $659.0 million, changed N/A from the prior year.
Treasury Shares climbed to $2.4 billion in Q1 2019 per ACB's latest filing, from $2.3 billion in the prior quarter.
Across five years, Treasury Shares topped out at $2.4 billion in Q1 2019 and bottomed at $659.0 million in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	4.13 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	1.30 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-297.63 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	35.35 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	1.16 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	19.00 Mn
10	Aurora Cannabis	235.30 Mn	162.99 Mn	25.75 Mn	-

Download Data